NCT02484911 Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting Status COMPLETED Phase PHASE3
NCT02462473 A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry Status TERMINATED Phase PHASE2
NCT02447835 Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction Status COMPLETED Phase PHASE1
NCT02435654 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia Status COMPLETED Phase PHASE4
NCT02431702 A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform Status COMPLETED Phase PHASE3
NCT02400866 A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy Status UNKNOWN Phase PHASE2
NCT02307396 Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Status COMPLETED Phase PHASE4
NCT02290470 Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel Status UNKNOWN Phase PHASE2
NCT02287259 Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study) Status COMPLETED Phase PHASE4
NCT02192723 A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia Status COMPLETED Phase NA
NCT02129478 Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study Status COMPLETED Phase PHASE2
NCT02116530 Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy Status COMPLETED Phase PHASE3
NCT02097823 Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy Status COMPLETED Phase PHASE2
NCT02088060 A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients Status TERMINATED Phase PHASE2
NCT02051387 Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study Status COMPLETED Phase PHASE1
NCT01977300 Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode Status COMPLETED Phase PHASE3
NCT01920802 Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo Status COMPLETED Phase PHASE4